References
- Finlayson B. Physicochemical aspects of urolithiasis. Kidney Int 1978;13:344–60.
- Wilcox WR, Khalaf A, Weinberger A, Kippen I, Klinenberg JR. Solubility of uric acid and monosodium urate. Med Biol Eng 1972;10:522–31.
- Grases F, Söhnel O, Vilacampa AI, March JG. Phosphates precipitating from artificial urine and fine structure of phosphate renal calculi. Clin Chim Acta 1996;244:45–67.
- Hess B. Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi. Ther Umsch Rev Ther 2003;60:79–87.
- Grases F, Costa-Bauzá A, Ramis M, Montesinos V, Conte A. Simple classification of renal calculi closely related to their micromorphology and etiology. Clin Chim Acta 2002;322:29–36.
- Grases F, García-Ferragut L, Costa-Bauzá A, Conte A, García-Raja A. Simple test to evaluate the risk of urinary calcium stone formation. Clin Chim Acta 1997;263:43–55.
- Grases F, Perelló J, Isern B, Prieto RM. Determination of myo-inositol hexakisphosphate (phytate) in urine by inductively coupled plasma atomic emission spectrometry. Anal Chim Acta 2004;510:41–3.
- Tiselius HG. An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease. Clin Chim Acta 1982;122:409–18.
- Tiselius HG. Risk formulas in calcium oxalate urolithiasis. World J Urol 1997;15:176–85.
- Galán JA, Conte A, Llobera A, Costa-Bauzá A, Grases F. A comparative study between etiological factors of calcium oxalate monohydrate and calcium oxalate dihydrate urolithiasis. Urol Int 1996;56:79–85.
- Grases F, Costa-Bauzá A. Phytate (IP6) is a powerful agent for preventing calcifications in biological fluids: usefulness in renal lithiasis treatment. Anticancer Res 1999;19:3717–22.
- Curhan GC, Willett WC, Knight EL, Stampfer MJ. Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II. Arch Intern Med 2004;164:885–91.
- Hallson PC, Rose GA. Crystalluria in normal subjects and in stone formers with and without thiazide and cellulose phosphate treatment. Br J Urol 1976;48:515–24.
- Buli P, Brunocilla E, Tiozzi E, Platania A, Cortecchia V. Crystalluria during prophylactic treatment of urinary lithiasis with allopurinol, hydrochlorothiazide, manganese oxide, diphosphonates and propionohydroxamic acid. Nephrologie 1984;5:213–16.
- Ahlstrand C, Tiselius HG, Larsson L. Studies on crystalluria in calcium oxalate stone formers. Urol Res 1984;2:103–6.
- Elliot JS, Rabinowitz IN. Calcium oxalate crystalluria: crystal size in urine. J Urol 1980;123:324–7.
- Robert M, Boularan AM, Delbos O, Monnier L, Grasset D. Evaluation of the risk of stone formation: study on crystalluria in patients with recurrent calcium oxalate urolithiasis. Eur Urol 1996;29:456–61.
- Robert M, Boularan AM, Delbos O, Guiter J, Descomps B. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects. Urol Int 1998;60:41–6.